Entity Details
| Primary name |
CATF_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q9UBX1 |
| EntryName | CATF_HUMAN |
| FullName | Cathepsin F |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 484 |
| SequenceStatus | complete |
| DateCreated | 2001-01-24 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Lysosome |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR000169 | Cysteine peptidase, cysteine active site | Site | Active site |
| IPR000668 | Peptidase C1A, papain C-terminal | Domain | Domain |
| IPR013201 | Cathepsin propeptide inhibitor domain (I29) | Domain | Domain |
| IPR025660 | Cysteine peptidase, histidine active site | Site | Active site |
| IPR038765 | Papain-like cysteine peptidase superfamily | Family | Homologous superfamily |
| IPR039417 | Papain-like cysteine endopeptidase | Domain | Domain |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 615362 | OMIM | Ceroid lipofuscinosis, neuronal, 13 (CLN13) | A form of neuronal ceroid lipofuscinosis characterized by adult onset of progressive cognitive decline and motor dysfunction leading to dementia and often early death. Some patients develop seizures. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
| Drug | Name | Source | Type |
| DB01810 | [1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester | Drugbank | small molecule |
| DB01871 | [1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester | Drugbank | small molecule |
| DB02243 | 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide | Drugbank | small molecule |
| DB03536 | Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate | Drugbank | small molecule |
| DB03573 | WRR-99 | Drugbank | small molecule |
| DB03691 | WRR-112 | Drugbank | small molecule |
| DB07913 | HOMOPHENYLALANINYLMETHANE | Drugbank | small molecule |
| DB08775 | Benzoyl-tyrosine-alanine-fluoro-methyl ketone | Drugbank | small molecule |
Interactions
2 interactions